Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203891 · ClinicalTrials.gov registry record
Single Photon Emission Computed Tomography of the Normal Human Brain
A clinical trial of Normal Human Subjects, sponsored by Amen Clinics.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT01203891 is a study of Normal Human Subjects that has completed, run by Amen Clinics. The registered enrollment target is 97 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01203891, a study of Normal Human Subjects, has completed, sponsored by Amen Clinics.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to acquire a database of Single Photon Emission Computed Tomographic (SPECT) studies of the brains of normal human subjects in resting and concentrating states. The database will provide a basis for subsequent investigation of meaningful brain differences between clinical and normal subject groups
Conditions Studied
Study Locations (1)
California
- Amen Clinics, Inc. - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2003-01 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01203891
The ClinicalTrials.gov registry entry for NCT01203891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amen Clinics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Normal Human Subjects appearing as the primary indexed condition, and to 0 interventions.
NCT01203891 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01203891 about?
NCT01203891 is a clinical study titled "Single Photon Emission Computed Tomography of the Normal Human Brain". The objective of the study is to acquire a database of Single Photon Emission Computed Tomographic (SPECT) studies of the brains of normal human subjects in resting and concentrating states. The database will provide a basis for subsequent investigation of meaningful brain differences between clinic...
What is the current status of trial NCT01203891?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2003-01. Estimated completion is 2010-05.
What conditions does trial NCT01203891 study?
This clinical trial studies the following conditions: Normal Human Subjects.
Who is sponsoring clinical trial NCT01203891?
This trial is sponsored by Amen Clinics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01203891 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.